Developing an assay for tryptophan metabolites in order to determine their impact on the pathogenicity of Chlamydia trachomatis

Posters | 2012 | Agilent TechnologiesInstrumentation
GC/MSD, GC/SQ
Industries
Metabolomics, Clinical Research
Manufacturer
Agilent Technologies
Downloadable PDF for viewing
 

Similar PDF

Metabolic Pathway Analysis Solutions
Metabolic Pathway Analysis Solutions
2024|Shimadzu|Brochures and specifications
Metabolomics of Carbon-Fixing Mutants of Cyanobacteria by GC/Q-TOF
Metabolomics of Opiate-Induced Changes in Murine Brain by GC/Q-TOF
Quantitation of Gut Microbiota‑Derived Indole Metabolites by Ion Pairing dMRM LC/QQQ